These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2841709)

  • 21. Intermittent-access binge consumption of sweet high-fat liquid does not require opioid or dopamine receptors in the nucleus accumbens.
    Lardeux S; Kim JJ; Nicola SM
    Behav Brain Res; 2015 Oct; 292():194-208. PubMed ID: 26097003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nontolerance to the opioid antagonism of naltrexone.
    Kleber HD; Kosten TR; Gaspari J; Topazian M
    Biol Psychiatry; 1985 Jan; 20(1):66-72. PubMed ID: 2981129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delta opiate receptors mediate tail-shock induced antinociception at supraspinal levels.
    Watkins LR; Wiertelak EP; Maier SF
    Brain Res; 1992 Jun; 582(1):10-21. PubMed ID: 1323369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central opioid receptors differentially regulate the nalmefene-induced suppression of ethanol- and saccharin-reinforced behaviors in alcohol-preferring (P) rats.
    June HL; Cummings R; Eiler WJ; Foster KL; McKay PF; Seyoum R; Garcia M; McCane S; Grey C; Hawkins SE; Mason D
    Neuropsychopharmacology; 2004 Feb; 29(2):285-99. PubMed ID: 14603266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duration of opioid receptor blockade determines biotherapeutic response.
    McLaughlin PJ; Zagon IS
    Biochem Pharmacol; 2015 Oct; 97(3):236-46. PubMed ID: 26119823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethanol palatability and consumption by high ethanol-drinking rats: manipulation of the opioid system with naltrexone.
    Coonfield DL; Kiefer SW; Ferraro FM; Sinclair JD
    Behav Neurosci; 2004 Oct; 118(5):1089-96. PubMed ID: 15506891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels.
    Watkins LR; Wiertelak EP; Maier SF
    Brain Res; 1992 Jun; 582(1):1-9. PubMed ID: 1354010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment.
    Romano SJ; Halmi KA; Sarkar NP; Koke SC; Lee JS
    Am J Psychiatry; 2002 Jan; 159(1):96-102. PubMed ID: 11772696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of lisdexamfetamine in a rat model of binge-eating.
    Vickers SP; Hackett D; Murray F; Hutson PH; Heal DJ
    J Psychopharmacol; 2015 Dec; 29(12):1290-307. PubMed ID: 26589243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of naloxone and naltrexone on the postprandial energy expenditure and endocrine pancreas response to a mixed meal in essential obesity].
    Signorini AM; Fondelli C; Garosi G; Borgogni L; Tanganelli I; Gragnoli G
    Boll Soc Ital Biol Sper; 1993; 69(7-8):447-52. PubMed ID: 7908805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeated administration of naltrexone and diprenorphine decreases food intake and body weight in squirrel monkeys.
    Herman BH; Holtzman SG
    Life Sci; 1984 Jan; 34(1):1-12. PubMed ID: 6319931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid antagonists in broadly defined behavioral addictions: a narrative review.
    Piquet-Pessôa M; Fontenelle LF
    Expert Opin Pharmacother; 2016; 17(6):835-44. PubMed ID: 26798982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine and μ-opioid receptor dysregulation in the brains of binge-eating female rats - possible relevance in the psychopathology and treatment of binge-eating disorder.
    Heal DJ; Hallam M; Prow M; Gosden J; Cheetham S; Choi YK; Tarazi F; Hutson P
    J Psychopharmacol; 2017 Jun; 31(6):770-783. PubMed ID: 28376679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naltrexone improves blood glucose control in type 1 diabetic women with severe and chronic eating disorders.
    Raingeard I; Courtet P; Renard E; Bringer J
    Diabetes Care; 2004 Mar; 27(3):847-8. PubMed ID: 14988322
    [No Abstract]   [Full Text] [Related]  

  • 35. Examining the utility of narrowing anorexia nervosa subtypes for adults.
    Peterson CB; Pisetsky EM; Swanson SA; Crosby RD; Mitchell JE; Wonderlich SA; Le Grange D; Hill L; Powers P; Crow SJ
    Compr Psychiatry; 2016 May; 67():54-8. PubMed ID: 27095335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of opioid antagonism on food intake behavior and body weight in a biobehavioral model of obese binge eating.
    Jarosz PA; Metzger BL
    Biol Res Nurs; 2002 Apr; 3(4):198-209. PubMed ID: 12184663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
    Younger J; Noor N; McCue R; Mackey S
    Arthritis Rheum; 2013 Feb; 65(2):529-38. PubMed ID: 23359310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opiate antagonists and long-term analgesic reaction induced by inescapable shock in rats.
    Maier SF; Davies S; Grau JW; Jackson RL; Morrison DH; Moye T; Madden J; Barchas JD
    J Comp Physiol Psychol; 1980 Dec; 94(6):1172-83. PubMed ID: 6259220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Opiate hypothesis of the origin of early childhood autism and sequelae for psychopharmacotherapy].
    Lensing P; Klingler D; Panksepp J; Huber M; Saria A; Hackenberg B; Adam H
    Z Kinder Jugendpsychiatr; 1992 Sep; 20(3):185-96. PubMed ID: 1329399
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological interventions for binge eating: lessons from animal models, current treatments, and future directions.
    Berner LA; Bocarsly ME; Hoebel BG; Avena NM
    Curr Pharm Des; 2011; 17(12):1180-7. PubMed ID: 21492094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.